Vaccines
Findings from the United States and Iceland describe new data in vaccines research
Published in Vaccine Weekly, July 12th, 2006
Study 1: Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge.
According to recent research from the United States, "Mannheimia haemolytica outer membrane protein P1pE, a major immunogenic outer membrane lipoprotein has identical sequences in serotypes 1 (S1) and S6. Recombinant outer membrane lipoprotein PlpE (rPLpE) from M. haemolytica S1 was added to commercial M. haemolytica S1 vaccines to determine if it would enhance...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-07-12)
More Articles from Vaccine Weekly
- Herpes Vaccine
CpG oligodeoxynucleotide is potent adjuvant for vaccination against genital herpes - Influenza Vaccine
Inactivated influenza vaccine prevents otitis media in children - Monkeypox Vaccine
Highly attenuated vaccinia virus vaccine protects monkeys against monkeypox - Pertussis Vaccine
Bordetella pertussis filamentous hemagglutinin is vaccine candidate - Streptococcal Vaccine
Tetra-epitopic peptide vaccine protects against group A streptococcus - Alzheimer Disease
A-beta42 gene vaccine reduces brain amyloid plaque burden in mice - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
